Metastatic breast cancer survivors may have a poorer survival rate if they have diabetes and inadequately controlled blood sugar levels.
Metastatic breast cancer survivors may have a poorer survival rate if they have diabetes and inadequately controlled blood sugar levels. This is the first study to specifically examine the effect of blood sugar control on cancer outcomes in patients with advanced breast cancer, according to lead researcher Y.M. Melody Cheung, M.D., of Brigham and Women’s Hospital, Harvard Medical School in Boston, Mass.
‘In patients with breast cancer who have a relatively good prognosis despite their cancer diagnosis, a more proactive management of blood sugar may lead to a longer lifespan.’
To date, there has been little research conducted on the effects of diabetes, and in particular, the impact of poor blood sugar control on advanced breast cancer outcomes. Existing studies have primarily focused on patients with early rather than advanced cancer. Researchers studied 488 patients with metastatic breast cancer. Half had diabetes. The study found that overall survival at five years was similar between the two groups.
However, amongst those that survived at least 8 years after their cancer diagnosis, survival for those without diabetes was better than those with diabetes (87% vs. 67% at 10 years).
In these longer-term survivors, survival was also better among those with good blood sugar control compared with those with poor blood sugar control (83% vs. 63% at 10 years).
Diabetes and Worse Outcomes in Breast Cancer Survivors Linked
“These findings are important as they suggest that diabetes treatment and blood sugar goals should be tailored specifically to patients even with advanced cancer based on their projected prognosis,” she added.“It remains uncertain whether control of blood sugars in patients with diabetes and breast cancer can improve the outcomes of the cancer itself,” Cheung said.
Advertisement
Source-Eurekalert